Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Hepatitis B

Click on the title for more information (where available).

Jones J, Colquitt J, Shepherd J, Harris P, Cooper K. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B. Evidence Review Group report Health Technology Assessment 2010;14, (Suppl 1).

Hartwell D, Jones J, Harris P, Cooper K. Telbividine for the treatment of chronic hepatitis B infection. Health Technology Assessment 2009;13(Suppl 3):23-3.

Jones J and Shepherd J. Estimating the cost effectiveness of single agent and combination anti-viral treatment strategies for patients with chronic hepatitis B. Oral presentation to V Annual Meeting of Health Technology Assessment International July 6-9th 2008, Montreal, Canada. 2009.

Jones J, Shepherd J, Baxter L, Gospodarevskaya E, Hartwell D, Harris P et al. Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation. Health Technology Assessment 2009;13(35):1-196.

Shepherd J, Gospodarevskaya E, Frampton GK, Cooper K. Entecavir for the treatment of chronic hepatitis B infection. Health Technology Assessment 2009;13(Suppl 3):31-6.

Takeda A, Jones J, Shepherd J, Davidson P, Price A. A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B. Journal of Viral Hepatitis 2007;14:75-88.

Jones J, Shepherd J, Takeda A, Davidson P, and Price A. Economic evaluation of adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic Hepatitis B. HTAi Annual Meeting. 2006.

Shepherd J, Jones J, Takeda A, Davidson P, Price A. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B - a systematic review and economic evaluation. Health Technology Assessment 2006;10(28).

Takeda A, Shepherd J, Jones J, Davidson P, and Price A. A systematic review of adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B. HTAi Annual Meeting. 2006.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×